BR9706741A - Processo para a fabricação de implantes contendo peptídeos bioativos - Google Patents

Processo para a fabricação de implantes contendo peptídeos bioativos

Info

Publication number
BR9706741A
BR9706741A BR9706741A BR9706741A BR9706741A BR 9706741 A BR9706741 A BR 9706741A BR 9706741 A BR9706741 A BR 9706741A BR 9706741 A BR9706741 A BR 9706741A BR 9706741 A BR9706741 A BR 9706741A
Authority
BR
Brazil
Prior art keywords
copolymer
mixture
aseptically
peptide
implant
Prior art date
Application number
BR9706741A
Other languages
English (en)
Inventor
Romano Deghenghi
Original Assignee
Romano Deghenghi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26699745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9706741(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Romano Deghenghi filed Critical Romano Deghenghi
Publication of BR9706741A publication Critical patent/BR9706741A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9706741A 1996-09-04 1997-07-28 Processo para a fabricação de implantes contendo peptídeos bioativos BR9706741A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2544496P 1996-09-04 1996-09-04
US08/897,942 US5945128A (en) 1996-09-04 1997-07-21 Process to manufacture implants containing bioactive peptides
PCT/EP1997/004095 WO1998009613A1 (en) 1996-09-04 1997-07-28 Process to manufacture implants containing bioactive peptides

Publications (1)

Publication Number Publication Date
BR9706741A true BR9706741A (pt) 1999-07-20

Family

ID=26699745

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9706741A BR9706741A (pt) 1996-09-04 1997-07-28 Processo para a fabricação de implantes contendo peptídeos bioativos

Country Status (14)

Country Link
US (3) US5945128A (pt)
EP (1) EP0858323B1 (pt)
JP (1) JPH11514678A (pt)
KR (1) KR100343645B1 (pt)
CN (1) CN1200032A (pt)
AT (1) ATE262889T1 (pt)
AU (1) AU713123B2 (pt)
BR (1) BR9706741A (pt)
CA (1) CA2236595A1 (pt)
DE (1) DE69728371T2 (pt)
DK (1) DK0858323T3 (pt)
ES (1) ES2218696T3 (pt)
PT (1) PT858323E (pt)
WO (1) WO1998009613A1 (pt)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US5362442A (en) 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
US20040067157A1 (en) * 1993-07-22 2004-04-08 Clearant, Inc. Methods for sterilizing biological materials
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
EP1173151B1 (en) 1999-04-16 2003-07-09 Novo Nordisk A/S Dry, mouldable drug formulation
TW200800298A (en) 2000-01-27 2008-01-01 Zentaris Ag Compressed microparticles for dry injection
US20040086420A1 (en) * 2000-03-23 2004-05-06 Macphee Martin J. Methods for sterilizing serum or plasma
DE60127139T2 (de) * 2000-07-14 2007-12-13 Novo Nordisk A/S Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
US6362308B1 (en) * 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
KR100876538B1 (ko) * 2000-08-17 2008-12-31 아에테르나 젠타리스 게엠베하 Ｌｈｒｈ 길항제의 염의 제조방법
WO2002016557A2 (en) * 2000-08-21 2002-02-28 Rice University Tissue engineering scaffolds promoting matrix protein production
US6682695B2 (en) * 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
DE50210646D1 (de) * 2001-05-23 2007-09-20 Hexal Ag Verfahren zur herstellung von implantaten mittels lösungsmittelfreier herstellung eines homogenisats
US6696060B2 (en) * 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US20030031584A1 (en) * 2001-08-10 2003-02-13 Wilson Burgess Methods for sterilizing biological materials using dipeptide stabilizers
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
GB0122113D0 (en) * 2001-09-11 2001-10-31 Astrazeneca Ab Composition
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US20030095890A1 (en) * 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
US20030185702A1 (en) * 2002-02-01 2003-10-02 Wilson Burgess Methods for sterilizing tissue
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
US20030124023A1 (en) * 2001-12-21 2003-07-03 Wilson Burgess Method of sterilizing heart valves
WO2003097237A2 (en) * 2002-05-13 2003-11-27 Becton, Dickinson, And Company Protease inhibitor sample collection system
US6908591B2 (en) * 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
US20040013562A1 (en) * 2002-07-18 2004-01-22 Wilson Burgess Methods for sterilizing milk.
WO2004032750A1 (en) * 2002-10-10 2004-04-22 Becton Dickinson And Company Sample collection system with caspase inhibitor
EP2526996B1 (en) * 2002-12-20 2019-09-11 Xeris Pharmaceuticals, Inc. Formulation for intracutaneous injection
GB0304726D0 (en) * 2003-03-01 2003-04-02 Ardana Bioscience Ltd New Process
US9445901B2 (en) * 2003-03-12 2016-09-20 Deger C. Tunc Prosthesis with sustained release analgesic
WO2004096151A2 (en) * 2003-04-29 2004-11-11 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US20040224000A1 (en) * 2003-05-05 2004-11-11 Romano Deghenghi Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
US20050124965A1 (en) * 2003-12-08 2005-06-09 Becton, Dickinson And Company Phosphatase inhibitor sample collection system
US7114074B2 (en) * 2003-12-22 2006-09-26 Graphic Security Systems Corporation Method and system for controlling encoded image production using image signatures
WO2005067889A1 (en) * 2003-12-30 2005-07-28 Durect Corporation Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of active agents, preferably a gnrh
FR2865938B1 (fr) 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
WO2006009801A2 (en) * 2004-06-17 2006-01-26 Valera Pharmaceuticals, Inc. Compositions and methods for treating central precocious puberty
AU2005325213B2 (en) 2004-08-04 2010-10-07 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
CA2586856C (en) 2004-11-11 2015-04-07 The General Hospital Corporation Parathyroid hormone receptor activation and stem and progenitor cell expansion
EP2460408A1 (en) 2004-12-17 2012-06-06 deVGen N.V. Nematicidal compositions
CA2590239A1 (en) * 2004-12-23 2006-07-06 Durect Corporation Controlled release compositions
EP2455072A1 (en) * 2005-03-11 2012-05-23 Endo Pharmaceuticals Solutions Inc. Controlled release formulations of octreotide
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
US8882747B2 (en) * 2005-11-09 2014-11-11 The Invention Science Fund I, Llc Substance delivery system
EP1837014A1 (en) * 2006-03-21 2007-09-26 Hexal Ag Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue
US8206827B2 (en) * 2007-03-15 2012-06-26 Nanovere Technologies, Llc Dendritic polyurethane coating
US9120249B2 (en) * 2007-04-27 2015-09-01 Endo Pharmaceuticals Solutions Inc. Implant device release agents and methods of using same
EA019284B1 (ru) * 2007-06-06 2014-02-28 Дебиофарм Рисёрч Энд Мэньюфэкчуринг Са Фармацевтическая композиция с пролонгированным высвобождением, приготовленная из микрочастиц
US20090035351A1 (en) * 2007-07-20 2009-02-05 Medtronic Vascular, Inc. Bioabsorbable Hypotubes for Intravascular Drug Delivery
JP5502751B2 (ja) 2007-12-20 2014-05-28 エボニック コーポレイション 低残留溶媒濃度を有する微粒子を調製するためのプロセス
GB0810990D0 (en) * 2008-06-16 2008-07-23 Q Chip Ltd Device and method of making solid beads
RU2521291C2 (ru) * 2008-06-25 2014-06-27 Эндо Фармасьютикалз Солюшнз Инк. Имплантат октреотида, содержащий высвобождающее вещество
JP5622725B2 (ja) 2008-06-25 2014-11-12 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド．Ｅｎｄｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｓｏｌｕｔｉｏｎｓｉｎｃ． エキセナチド及び他のポリペプチド類の持続的送達
EP2246063A1 (en) * 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. Sustained release formulations comprising GnRH analogues
US8604101B2 (en) 2010-03-24 2013-12-10 Basf Se Process for producing aqueous dispersions of thermoplastic polyesters
CN102811802B (zh) 2010-03-24 2015-06-03 巴斯夫欧洲公司 生产热塑性聚酯的水分散体的方法
US20120046225A1 (en) 2010-07-19 2012-02-23 The Regents Of The University Of Colorado, A Body Corporate Stable glucagon formulations for the treatment of hypoglycemia
AU2012225268B2 (en) 2011-03-10 2016-10-20 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
CA2849663A1 (en) 2011-09-23 2013-03-28 Basf Se Use of an aqueous dispersion of biodegradable polyesters
DE102011114864A1 (de) 2011-10-05 2013-04-11 Acino Ag Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
ES2574761T3 (es) 2011-10-31 2016-06-21 Xeris Pharmaceuticals, Inc. Formulaciones para el tratamiento de la diabetes
KR102037555B1 (ko) * 2012-05-14 2019-10-28 데이진 가부시키가이샤 멸균 조성물
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
WO2015165821A1 (de) * 2014-04-30 2015-11-05 Acino Supply Ag Verfahren und vorrichtung zur herstellung einer pharmazeutischen zusammensetzung
AU2015300944B2 (en) 2014-08-06 2019-07-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
AU2018275686B2 (en) 2017-06-02 2024-02-01 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
CH681425A5 (pt) * 1990-11-14 1993-03-31 Debio Rech Pharma Sa
CH679207A5 (pt) * 1989-07-28 1992-01-15 Debiopharm Sa
CH685285A5 (fr) * 1991-12-02 1995-05-31 Debio Rech Pharma Sa Procédé de préparation d'une composition pharmaceutique contenant des sels de peptides.
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides

Also Published As

Publication number Publication date
KR20000064317A (ko) 2000-11-06
US6159490A (en) 2000-12-12
DE69728371D1 (de) 2004-05-06
AU4012197A (en) 1998-03-26
DK0858323T3 (da) 2004-06-28
CA2236595A1 (en) 1998-03-12
KR100343645B1 (ko) 2002-08-22
WO1998009613A1 (en) 1998-03-12
EP0858323A1 (en) 1998-08-19
EP0858323B1 (en) 2004-03-31
DE69728371T2 (de) 2005-01-13
ATE262889T1 (de) 2004-04-15
US5945128A (en) 1999-08-31
ES2218696T3 (es) 2004-11-16
JPH11514678A (ja) 1999-12-14
AU713123B2 (en) 1999-11-25
PT858323E (pt) 2004-08-31
CN1200032A (zh) 1998-11-25
US6077523A (en) 2000-06-20

Similar Documents

Publication Publication Date Title
BR9706741A (pt) Processo para a fabricação de implantes contendo peptídeos bioativos
CA2085750C (en) Osteoinductive pharmaceutical formulations
US5246457A (en) Xenogeneic collagen/mineral preparations in bone repair
KR102338123B1 (ko) 탄산 수산화인회석을 함유하는 이식가능한 복합체
ES2326467T3 (es) Implante para aplicaciones ortopedicas.
FI98136C (fi) Kudosolosuhteissa hajoava materiaali ja menetelmä sen valmistamiseksi
SE434013B (sv) Depa for verksamt emne pa basis av kollagen, ett forfarande for framstellning derav samt anvendning derav
JP4703926B2 (ja) 骨形成蛋白をデリバリーするためのヒアルロン酸の処方
AU2605592A (en) Polymeric compositions useful as controlled release implants
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
CN110180027A (zh) 具有改进的操作特征的脱矿质骨基质
JPH1133105A (ja) 賦形剤／活性化合物組み合わせ物を含んでなるインプラント材料
CN111511415A (zh) 干式植入物组合物和可注射的水性植入物制剂
DE59706445D1 (de) Verfahren zur herstellung eines implantates, bestehend aus einem resorbierbaren trägermaterial, eine medizinische wirksubstanz wie ein pharmazeutika, antibiotika, cytostatika oder hormon enthaltend
EP2953657B1 (en) Tissue substitute material with biologically active coating
WO2006010547A2 (de) Bioresorbierbares material zur füllung von knochendefekten
EP0845993B1 (de) Verwendung von plasminogenaktivatoren zum lokalen knochenaufbau
DE10159291A1 (de) Verfahren zur Herstellung eines partiellen oder vollständigen Wirkstoffüberzuges auf und in Implantaten und Onplantaten
Tuomo et al. Fixation of distal femoral osteotomies with self-reinforced poly (L/DL) lactide 70: 30/bioactive glass composite rods. An experimental study on rats
EP3609548B1 (de) Natives knochenersatzmaterial zur förderung der osteogenese, verfahren zu dessen herstellung und verwendungen
MXPA98003452A (en) Process to manufacture implants containing bioactive peptides

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1834 DE 01/03/2006.